Akebia Therapeutics
AKBA
#6958
Rank
C$0.56 B
Marketcap
$2.70
Share price
4.02%
Change (1 day)
114.75%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of June 2024 : C$54.93 Million

According to Akebia Therapeutics's latest financial reports the company has C$54.93 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$56.93 M-53.62%
2022-12-31C$0.12 B-35.7%
2021-12-31C$0.19 B-44.28%
2020-12-31C$0.34 B77.61%
2019-12-31C$0.19 B-55.97%
2018-12-31C$0.43 B9.66%
2017-12-31C$0.39 B14.2%
2016-12-31C$0.34 B82.16%
2015-12-31C$0.19 B51.95%
2014-12-31C$0.12 B264.72%
2013-12-31C$34.65 M2023.72%
2012-12-31C$1.63 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$12.53 B 22,713.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.49 B 35,394.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$28.22 B 51,286.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.37 B 586.69%๐Ÿ‡บ๐Ÿ‡ธ USA